{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:46:52Z","timestamp":1778849212513,"version":"3.51.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      The necessity of thyrotropin (TSH) suppression therapy for papillary thyroid cancer (PTC) after lobectomy has been challenged. This study aims to evaluate on-demand\n                      <jats:sc>l<\/jats:sc>\n                      -thyroxine replacement therapy for post-lobectomy PTC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This prospective study cohort included adult patients with low- to intermediate-risk PTC, who underwent lobectomy (2021\u20132023).\n                      <jats:sc>l<\/jats:sc>\n                      -Thyroxine supplementation was given after surgery only if serum TSH exceeded the upper limit of the reference range (&gt;5.91 mU\/L). Retrospective controls were selected from the institute database (2000\u20132014) after being matched with prospective patients and treated according to the guideline (TSH, 0.5\u20132 mU\/L). The primary endpoint was prognosis, including structural recurrence and biochemical response. The secondary endpoint was the euthyroidism rate without thyroxine. The Kaplan\u2013Meier curve was used to estimate recurrence-free survival (RFS) and euthyroidism rates, and compared using the log-rank test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 381 patients who were enrolled in the present study (median age 39\u00a0years, 70.6% female), no new cases were detected requiring\n                      <jats:sc>l<\/jats:sc>\n                      -thyroxine for elevated TSH at greater than year post surgery. In the prognostic evaluation, 333 cases were included, with a mean follow-up of 17\u00a0months, and 72.3% never underwent\n                      <jats:sc>l<\/jats:sc>\n                      -thyroxine supplementation. Comparison with the historical control group was conducted in 204 pairs of cases. No significant difference was observed in either 2-year RFS (test group vs. control group, 99.4% vs. 98.5%,\n                      <jats:italic toggle=\"yes\">P =<\/jats:italic>\n                      0.917) or biochemical responses among patients with negative thyroglobulin (Tg) antibody (rate of patients with increasing Tg, 21.6% vs. 21.6%,\n                      <jats:italic toggle=\"yes\">P&gt;<\/jats:italic>\n                      0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      On-demand\n                      <jats:sc>l<\/jats:sc>\n                      -thyroxine replacement therapy benefit three-fourths of post-lobectomy low- to intermediate-risk PTC patients avoid\n                      <jats:sc>l<\/jats:sc>\n                      -thyroxine supplementation, while preserving equivalent short-term treatment response and RFS.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003905","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T11:00:25Z","timestamp":1762772425000},"page":"3467-3473","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["On-demand l-thyroxine replacement therapy in post-lobectomy papillary thyroid cancer: a prospective nonrandomized controlled study"],"prefix":"10.1097","volume":"112","author":[{"given":"Siyuan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, Key Laboratory of Otolaryngology Head and Neck Surgery (Capital Medical University), Ministry of Education, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyao","family":"Xian","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwei","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongmin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-7978","authenticated-orcid":false,"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"1531\u201344","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"R2-20260512","first-page":"425\u201335","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"1\u2013133","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"1856\u201383","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"138\u201344","DOI":"10.1089\/thy.2021.0404","article-title":"Optimal serum thyrotropin level for patients with papillary thyroid carcinoma after lobectomy","volume":"32","author":"Xu","year":"2022","journal-title":"Thyroid"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"691\u201397","DOI":"10.1016\/j.eprac.2021.01.004","article-title":"Frequency of thyroid hormone replacement after lobectomy for differentiated thyroid cancer","volume":"27","author":"Schumm","year":"2021","journal-title":"Endocr Pract"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"75\u201380","DOI":"10.1016\/j.surg.2017.04.039","article-title":"Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American Thyroid Association guidelines?","volume":"163","author":"Cox","year":"2018","journal-title":"Surgery"},{"key":"R9-20260512","first-page":"100081","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of Artificial Intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1751143717711356","article-title":"Trache teams","volume":"19","author":"Parulekar","year":"2018","journal-title":"J Intensive Care Soc"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"515\u201321","DOI":"10.1507\/endocrj.EJ15-0635","article-title":"Changing trends in the management of well-differentiated thyroid carcinoma in Korea","volume":"63","author":"Lee","year":"2016","journal-title":"Endocr J"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"1250\u201357","DOI":"10.1016\/j.surg.2011.09.013","article-title":"Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study","volume":"150","author":"Sugitani","year":"2011","journal-title":"Surgery"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"e2211863","DOI":"10.1001\/jamanetworkopen.2022.11863","article-title":"Association of thyroid hormone treatment intensity with cardiovascular mortality among US Veterans","volume":"5","author":"Evron","year":"2022","journal-title":"JAMA Network Open"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"4046\u201353","DOI":"10.1200\/JCO.2013.49.1043","article-title":"Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study","volume":"31","author":"Klein Hesselink","year":"2013","journal-title":"J Clin Oncol"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"769074","DOI":"10.3389\/fendo.2021.769074","article-title":"Effect of thyroid-stimulating hormone suppression on muscle function after total thyroidectomy in patients with thyroid cancer","volume":"12","author":"Lee","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"271\u201380","DOI":"10.1210\/clinem\/dgac646","article-title":"Current controversies in low-risk differentiated thyroid cancer: reducing overtreatment in an era of overdiagnosis","volume":"108","author":"Ullmann","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"1164\u201370","DOI":"10.1089\/thy.2017.0177","article-title":"Thyrotropin suppressive therapy for low-risk small thyroid cancer: a propensity score-matched cohort study","volume":"27","author":"Park","year":"2017","journal-title":"Thyroid"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"150\u201357","DOI":"10.3803\/EnM.2019.34.2.150","article-title":"Postoperative thyroid-stimulating hormone levels did not affect recurrence after thyroid lobectomy in patients with papillary thyroid cancer","volume":"34","author":"Lee","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"390\u201396","DOI":"10.1002\/jso.25164","article-title":"The prognostic value of serum thyroid-stimulating hormone level post-lobectomy in low- and intermediate-risk papillary thyroid carcinoma","volume":"118","author":"Park","year":"2018","journal-title":"J Surg Oncol"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.21037\/atm-20-4890","article-title":"Analysis of the strategy of LT4 prescribing and TSH monitoring for thyroid carcinoma after lobectomy","volume":"8","author":"Wang","year":"2020","journal-title":"Ann Transl Med"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:23:40Z","timestamp":1778581420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003905","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"2025-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}